The first InGeNA quarterly forum for the year will be held of 17 March 2022.
The online event is open to employees of InGeNA member companies, as well as select groups and government agencies offered an invite to present and attend.

The purpose of each quarterly forum is to inform InGeNA members about relevant activities in the genomics landscape in Australia, particularly with regards to government news and regulatory change. It is also to maintain open lines of communication between InGeNA and select groups and government agencies.

This quarter, InGeNA will welcome guests from Medicines Australia and the Genomic Institute Queensland.

Elizabeth de Somer, CEO of Medicines Australia will discuss recent progress on the implementation of the Medicines Australia Strategic Agreement. Second speaker will be Kaye Hewson, Operations Director of the Genomic Institute, presenting on Establishing the Genomic Institute Queensland. Each presentation will be followed with an opportunity for Q&A and discussions with InGeNA members.

InGeNA member employees are invited to check your inbox for the direct invitation from InGeNA Program Manager, Carla Carroll, or contact Carla at carla@digitalhealth.org.au